Ernexa Therapeutics, Inc. (ERNA)
1.95
-0.16
(-7.58%)
USD |
NASDAQ |
Oct 30, 15:19
Ernexa Therapeutics Price to Book Value : 0.7132 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 0.7717 |
| October 28, 2026 | 0.7242 |
| October 27, 2026 | 0.729 |
| October 26, 2026 | 0.7088 |
| October 23, 2026 | 0.7553 |
| October 22, 2026 | 0.7589 |
| October 21, 2026 | 0.7717 |
| October 20, 2026 | 0.8193 |
| October 19, 2026 | 0.7242 |
| October 16, 2026 | 0.7644 |
| October 15, 2026 | 0.7937 |
| October 14, 2026 | 0.7717 |
| October 13, 2026 | 0.8083 |
| October 12, 2026 | 0.8083 |
| October 09, 2026 | 0.8778 |
| October 08, 2026 | 0.9107 |
| October 07, 2026 | 0.8741 |
| October 06, 2026 | 0.8174 |
| October 05, 2026 | 0.9875 |
| October 02, 2026 | 1.083 |
| October 01, 2026 | 1.083 |
| September 30, 2026 | 1.170 |
| September 29, 2026 | 1.156 |
| September 28, 2026 | 1.269 |
| September 25, 2026 | 1.26 |
| Date | Value |
|---|---|
| September 24, 2026 | 1.324 |
| September 23, 2026 | 1.335 |
| September 22, 2026 | 1.390 |
| September 21, 2026 | 1.448 |
| September 18, 2026 | 1.401 |
| September 17, 2026 | 1.375 |
| September 16, 2026 | 1.43 |
| September 15, 2026 | 1.492 |
| September 14, 2026 | 1.562 |
| September 11, 2026 | 1.523 |
| September 10, 2026 | 1.470 |
| September 09, 2026 | 1.470 |
| September 08, 2026 | 1.532 |
| September 04, 2026 | 1.576 |
| September 03, 2026 | 1.657 |
| September 02, 2026 | 1.660 |
| September 01, 2026 | 1.591 |
| August 31, 2026 | 1.671 |
| August 28, 2026 | 1.671 |
| August 27, 2026 | 1.732 |
| August 26, 2026 | 1.788 |
| August 25, 2026 | 1.801 |
| August 24, 2026 | 1.842 |
| August 21, 2026 | 1.778 |
| August 20, 2026 | 1.653 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cerenome, Inc. | 2.261 |
| ACADIA Pharmaceuticals, Inc. | 2.719 |
| Alnylam Pharmaceuticals, Inc. | 6.165 |
| Anika Therapeutics, Inc. | 2.042 |
| Savara, Inc. | 6.820 |
Price to Book Value Related Metrics
| Price | 1.95 |
| Earnings Yield | -970.4% |
| Market Cap | 2.282M |